Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension



Rating:

Share or cite this content

Citations should be made in the following way:
R. Osterhout (San Diego, CA, United States of America), K. Highland (Cleveland, OH, United States of America), R. Frantz (Rochester, MN, United States of America), D. Nickle (San Diego, CA, United States of America), J. Mcconnell (Louisville, KY, United States of America), C. Burger (Jacksonville, FL, United States of America), R. Roscigno (San Diego, CA, United States of America), M. Cravets (San Diego, CA, United States of America), R. Mccaffrey (San Diego, CA, United States of America), L. Zisman (San Diego, CA, United States of America), J. Bruey (San Diego, CA, United States of America), L. Howard (London, United Kingdom). Late Breaking Abstract - Evidence of target engagement and pathway modulation: biomarker analysis of the phase 1b inhaled seralutinib study. 601

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Heterogeneity of metabolism and activation in lower limb muscles during exercise in COPD: a preliminary data analysis Source: International Congress 2019 – Exercise physiopathology in various respiratory diseases Year: 2019 Late Breaking Abstract - A PET imaging study to confirm target engagement in the lungs of patients with IPF following a single dose of a novel inhaled avß6 integrin inhibitor Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019 Late Breaking Abstract - Microbiome-driven clusters in severe asthma derived from induced sputum: identification and stability over time. Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes Year: 2019 Late Breaking Abstract - Evaluation of the JNK inhibitor, CC-90001, in a phase 1b pulmonary fibrosis trial. Source: International Congress 2017 – Interstitial lung diseases (ILDs): novel pathogenetic pathways Year: 2017 Late Breaking Abstract - Biological phenotypes of ARDS show differential expression of genes involved in oxidative phosphorylation and immunomodulation: an illustration for the need of personalized medicine in ARDS. Source: International Congress 2018 – Ventilation and lung imaging in critically ill patients Year: 2018 Late Breaking Abstract - iPREDICT: Pilot study to develop predictive model of changes in asthma control Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases Year: 2019 Late Breaking Abstract - Validation of a tool for the assessment of disease awareness (DA) in COPD Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Late Breaking Abstract - Molecular mechanisms involved in early stage of pulmonary hypertension: experimental study Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018 Late Breaking Abstract - Enhanced immune activation pathways enriched in patients =70 years with severe COVID-19 Source: Virtual Congress 2021 – COVID19, acute respiratory failure and basic science Year: 2021 Late Breaking Abstract: Activation of the WNT/β-catenin pathway attenuates experimental emphysema Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 Late Breaking Abstract: EXHALE airway stents for emphysema (EASE) trial: CT analysis shows stent-based regional changes mediate early benefit & later loss Source: Annual Congress 2010 - State of the art imaging Year: 2010 Late Breaking Abstract - Functional investigation of the corticosteroid resistance candidate FKBP5 using a CRISPR-Cas9 knockout model Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Late Breaking Abstract - ND-L02-s0201 treatment leads to efficacy in preclinical IPF models Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Late Breaking Abstract - Multiple ascending dose study of the inhaled IL-4Ra antagonist, AZD1402/PRS-060, in mild asthmatics demonstrates robust FeNO reduction and a promising clinical profile for the treatment of asthma Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019 Late Breaking Abstract - Phase 1, first-in-human study of OATD-01, a dual chitinase inhibitor for the treatment of respiratory diseases Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018 Late Breaking Abstract - The roles of impulse oscillometry in detection of asthma control level. Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases Year: 2020 Late Breaking Abstract - Automated coaching for physical activity in COPD patients: results from a pilot study Source: International Congress 2017 – Innovation in pulmonary rehabilitation and chronic care Year: 2017 Late Breaking Abstract - Characterizing responders to benralizumab for severe asthma: pooled analysis of the SIROCCO and CALIMA studies Source: International Congress 2017 – Update and new perspectives in Airway Diseases Year: 2017 Late Breaking Abstract - B cell adaptive immune profile in emphysema-predominant COPD Source: International Congress 2019 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2019 Late Breaking Abstract - Endobronchial gene-expression clustering in COPD identifies a subgroup with higher level of lymphocytes and accelerated lung function decline Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018